医学
肥厚性心肌病
心脏病学
内科学
心力衰竭
心肌病
作者
Milind Y. Desai,S.E. Nissen,Theodore P. Abraham,Iacopo Olivotto,Pablo García‐Pavía,Renato D. Lopes,Nicolas Verheyen,Omar Wever‐Pinzon,Kathy Wolski,Wael A. Jaber,Lisa Mitchell,Deborah Davey,Jonathan Myers,Thomas A. Rano,Vandana Bhatia,Yue Zhong,Suzanne Carter-Bonanza,Victoria Florea,Ron Aronson,Anjali Owens
标识
DOI:10.1016/j.jchf.2024.11.013
摘要
are 66% ± 4% and 18 ± 6 mL/kg/min, respectively. ODYSSEY-HCM will report if mavacamten improves patient-reported health status and exercise capacity in patients with symptomatic nHCM. (A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy (ODYSSEY-HCM); NCT05582395).
科研通智能强力驱动
Strongly Powered by AbleSci AI